Europe's IMI announces launch of 2008 priorities
The Innovative Medicines Initiative, a collaboration between the European Federation of Pharmaceutical Industries and Associations and the European Commission, has announced the launch of its first presentation of the scientific priorities for the group in 2008. The event is scheduled for April 30 in Brussels, Belgium, at the EC headquarters.
Three areas of the drug development process are expected to feature at the briefing: safety and pharmacovigilance; efficacy; and education and training.
Attending the launch will be Janez Potocnik, the Commissioner for Science and Research and Arthur Higgins, the president of the EFPIA and also chief executive of Germany's Bayer Healthcare. Other attendees will be representatives from both the drug industry and the EC, with stakeholders from professional and patient organizations, academia and European governments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze